Dose Dependent Long-term In Vivo Remission of AML1/ETO Positive Acute Myeloid Leukemia with G-CSF

By Zomas A.   Stefanoudaki-Sofianatou K.   Fisfis M.   Anagnostopoulos N.I.  

Hematology, Vol. 9, Iss. 2, 2004-04 ,pp. : 107-111

Maney Publishing

Access to resources Recommend Favorite

Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia

By Hofmann W.   Heil G.   Zander C.   Wiebe S.   Ottmann O.   Bergmann L.   Hoeffken K.   Fischer J.   Knuth A.   Kolbe K.   Schmoll H.   Langer W.   Westerhausen M.   Koelbel C.   Hoelzer D.   Ganser A.  

Annals of Hematology, Vol. 83, Iss. 8, 2004-08 ,pp. : 498-503

Springer Publishing Company

Access to resources Recommend Favorite

Low dose daily rhGM-CSF application activates monocytes and dendritic cells in vivo

By Demir G.   Klein H.O.   Tuzuner N.  

Leukemia Research, Vol. 27, Iss. 12, 2003-12 ,pp. : 1105-1108

Elsevier

Access to resources Recommend Favorite

Imatinib and beyond—the new CML study IV: A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia

By Berger U.  

Annals of Hematology, Vol. 83, Iss. 4, 2004-04 ,pp. : 258-264

Springer Publishing Company

Access to resources Recommend Favorite

Acute myeloid/NK precursor cell leukemia with trisomy 4 and a novel point mutation in the extracellular domain of the G-CSF receptor in a patient with chronic idiopathic neutropenia

By Papadaki H.  

Annals of Hematology, Vol. 83, Iss. 6, 2004-06 ,pp. : 345-348

Springer Publishing Company

Access to resources Recommend Favorite